Atlas Trials

Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts

Clinical trial NCT04186650 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04186650
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Epidermolysis Bullosa Dystrophica, Recessive
Start date
2020-01-10
Primary completion
2027-06-09
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.